WOO_X_Additional_s.png
WOO X Ranks Top Trading Exchange for Jeo Boden (BODEN)
June 06, 2024 05:12 ET | WOO X
VICTORIA, Seychelles, June 06, 2024 (GLOBE NEWSWIRE) -- WOO X, a leading global centralized crypto futures and spot trading platform, has solidified its position as the number one centralized spot...
mobia-logo.png
Ryan Conn Joins MOBIA as Enterprise Account Executive for Alberta
June 06, 2024 05:08 ET | MOBIA Technology Innovations
CALGARY, Alberta, June 06, 2024 (GLOBE NEWSWIRE) -- MOBIA, Canada’s leading business transformation partner, is excited to welcome Ryan Conn as Enterprise Account Executive for Alberta. A natural...
22157.jpg
Global Premenstrual Syndrome (PMS) & Menstrual Health Supplements Market Report 2024-2033: Combined Nutritional Supplements Lead the Way in $37.23 Billion PMS and Menstrual Health Market by 2033
June 06, 2024 05:02 ET | Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market - A Global and Regional Analysis: Focus on Product, Indication, Formulation, Sales...
Johnson & Johnson be
Johnson & Johnson beantragt bei der Europäischen Arzneimittel-Agentur die Zulassung der subkutanen Formulierung von RYBREVANT®▼ (amivantamab) für die Behandlung von Patienten mit EGFR-mutiertem nicht-kleinzelligem Lungenkrebs
June 06, 2024 05:01 ET | Janssen Cilag International NV
Die Einreichung wird durch Daten aus der Phase-III-Studie PALOMA-3 unterstützt, die auf der Jahrestagung der American Society of Clinical Oncology (ASCO) vorgestellt wurden1 Neue Formulierung zeigte...
QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2024
June 06, 2024 05:00 ET | QuantaSing Group Limited
BEIJING, June 06, 2024 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced its unaudited...
ITM_Logo_Claim_RGB_high-res.png
ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing
June 06, 2024 05:00 ET | ITM Isotope Technologies Munich SE
Proceeds to support development of ITM’s targeted radiopharmaceutical pipeline and preparations for potential market launch of phase III lead candidate, ITM-11, as it nears clinical read-out Funds...
Sagimet-Logo-for-light-bg-FIN.png
Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024
June 06, 2024 05:00 ET | Sagimet Biosciences Inc.
Denifanstat achieved statistically significant results on primary and secondary liver biopsy endpoints in the ITT population, including both histology endpoints recommended in the FDA draft guidance...
sphericalinsightsoptionblue.png
Global Robotic Dentistry Market Trends To Exceed USD 1,994.14 Million By 2033 | CAGR Of 15.86%
June 06, 2024 05:00 ET | SPHERICAL INSIGHTS LLP
New York, United States , June 06, 2024 (GLOBE NEWSWIRE) -- The Global Robotic Dentistry Market Size is to Grow from USD 457.38 Million in 2023 to USD 1,994.14 Million by 2033, at a CAGR of 15.86%...
Alm. Brand Group.png
Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties
June 06, 2024 04:57 ET | Alm. Brand A/S
Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties Pursuant to article 19 of the EU Regulation 596/2014 and Alm. Brand A/S is required to...
Alm. Brand Group.png
Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties
June 06, 2024 04:54 ET | Alm. Brand A/S
Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties Pursuant to article 19 of the EU Regulation 596/2014 and Alm. Brand A/S is required to...